HIV prevention drug could reduce cases globally but USAID cuts prevent access, say experts
Experts at the Aids 2026 Conference warn that US foreign aid cuts, specifically the dissolution of USAID, are hindering global access to life-saving HIV prevention drugs like lenacapavir. Despite the drug's high efficacy, funding declines threaten to reverse progress in global HIV reduction.
People protest against funding cuts and drug patents during the 26th International Aids Conference in Rio de Janeiro on Monday. via Getty Images People protest against funding cuts and drug patents during the 26th International Aids Conference in Rio de Janeiro on Monday. via Getty Images Aids and HIV HIV prevention drug could reduce cases globally but USAID cuts prevent access, say experts Injectable PrEP drug holds promise but investment in HIV prevention has declined dramatically worldwide
Get the full story
Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.
Create free accountAlready have an account? Sign in